Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 139th ranked industry out of 145 stock market industries

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
TLX	TELIX PHARMACEUTICALS LTD	$4.07B	-1.40%	-0.50%	3.82%	5.50%	1.80	1.43	53.10%	-0.90%	4.43%
KYMR	KYMERA THERAPEUTICS INC	$9.11B	-21.50%	-19.50%	-19.01%	-22.00%	0.09	10.34	100.00%	-285.30%	-285.02%
EDIT	EDITAS MEDICINE INC	$453.06M	-196.60%	-38.20%	-44.97%	-126.80%	1.26	3.19	100.00%	-157.30%	-161.60%
RGNX	REGENXBIO INC	$703.04M	-220.10%	-46.00%	-50.82%	-28.30%	4.39	2.86	86.40%	-112.60%	-88.54%
NAGE	NIAGEN BIOSCIENCE INC	$243.71M	20.50%	15.00%	18.60%	88.80%	0.29	6.50	64.20%	12.40%	13.19%
SLGL	SOL-GEL TECHNOLOGIES LTD	$254.72M	-3.20%	-2.60%	-2.00%	-4.00%	0.14	8.84	100.00%	-5.70%	-5.70%
APMD	APNIMED INC	N/A	N/A	N/A	N/A	N/A	-0.45	1.91	N/A	N/A	N/A
RNAC	CARTESIAN THERAPEUTICS INC	$259.74M	N/A	-48.30%	-53.76%	-109.70%	-3.54	7.48	100.00%	-10,422.50%	-10,848.48%
WHWK	WHITEHAWK THERAPEUTICS INC	$266.23M	-53.90%	-50.00%	-43.64%	-80.40%	0.06	17.38	N/A	N/A	N/A
FATE	FATE THERAPEUTICS INC	$319.37M	-58.90%	-39.40%	-51.10%	-39.90%	0.59	5.85	100.00%	-2,056.80%	-2,056.79%
NBTX	NANOBIOTIX SA	$1.87B	N/A	-35.50%	-85.10%	-27.90%	-1.80	1.09	100.00%	-73.50%	-26.77%
ATYR	ATYR PHARMA INC	$52.38M	-95.60%	-69.70%	-104.07%	-83.50%	0.44	5.12	100.00%	-32,003.70%	-32,003.68%
NAUT	NAUTILUS BIOTECHNOLOGY INC	$113.38M	-37.60%	-30.80%	-36.48%	-30.20%	0.25	10.14	92.10%	-29,747.90%	-29,747.89%
ALXO	ALX ONCOLOGY HOLDINGS INC	$266.87M	-90.30%	-67.30%	-54.42%	-94.30%	0.18	9.71	N/A	N/A	N/A
BRVE	BRAVEHEART BIO INC	N/A	N/A	N/A	N/A	N/A	-0.13	8.11	N/A	N/A	N/A
BLSM	BLOSSOMHILL THERAPEUTICS INC	N/A	N/A	N/A	N/A	N/A	-0.25	7.40	N/A	N/A	N/A
ASMB	ASSEMBLY BIOSCIENCES INC	$433.39M	-4.20%	-3.10%	-3.18%	-5.10%	0.19	6.65	N/A	N/A	N/A
PHAT	PHATHOM PHARMACEUTICALS INC	$688.47M	N/A	-35.00%	-20.57%	-6.70%	-1.95	1.92	82.90%	-41.30%	-14.87%
AGIO	AGIOS PHARMACEUTICALS INC	$1.95B	-35.70%	-33.10%	-39.71%	-37.10%	0.08	10.22	92.00%	-418.20%	-419.27%
MESO	MESOBLAST LTD	$2.18B	-18.20%	-13.10%	-10.17%	-72.20%	0.36	1.58	80.50%	-144.30%	-101.79%
PRTA	PROTHENA CORP PUBLIC LTD CO	$473.33M	-15.00%	-13.20%	-15.24%	622.90%	0.06	25.05	100.00%	-80.70%	-81.33%
CHRS	COHERUS ONCOLOGY INC	$186.95M	-183.40%	-42.90%	-106.38%	-562.00%	2.14	1.77	68.90%	-259.40%	-241.58%
CNXU	CONEXEU SCIENCES INC	$199.08M	N/A	N/A	N/A	N/A	0.14	7.89	N/A	N/A	N/A
CGEN	COMPUGEN LTD	$227.34M	42.60%	26.10%	30.45%	156.80%	0.56	5.72	86.90%	47.60%	47.63%
MGNX	MACROGENICS INC	$249.17M	-147.80%	-28.40%	-47.34%	-26.80%	9.28	1.90	74.40%	-44.80%	-36.75%
BLTE	BELITE BIO INC	$6.99B	-16.90%	-16.60%	-10.07%	-29.10%	0.01	50.02	N/A	N/A	N/A
TGTX	TG THERAPEUTICS INC	$7.64B	72.30%	33.60%	10.14%	10.30%	1.71	4.27	82.40%	55.20%	17.40%
PALI	PALISADE BIO INC	$372.94M	-33.50%	-31.80%	-26.16%	956.50%	0.05	24.26	100.00%	-6,388.20%	-6,386.60%
MRNA	MODERNA INC	$24.18B	-39.20%	-26.90%	-36.63%	-34.90%	0.62	2.30	23.40%	-141.40%	-138.55%
NVCT	NUVECTIS PHARMA INC	$632.41M	-184.30%	-105.20%	-306.61%	229.00%	1.46	1.68	N/A	N/A	N/A
ARWR	ARROWHEAD PHARMACEUTICALS INC	$12.61B	-60.50%	-17.40%	-11.34%	-8.50%	3.54	5.90	100.00%	-47.80%	-30.96%
OCUL	OCULAR THERAPEUTIX INC	$2.14B	-59.90%	-46.00%	-46.62%	-301.30%	0.29	13.11	87.10%	-579.10%	-557.20%
CRSP	CRISPR THERAPEUTICS AG	$5.23B	-24.40%	-18.30%	-17.80%	-18.00%	0.52	17.85	100.00%	-3,368.70%	-3,346.08%
DNTH	DIANTHUS THERAPEUTICS INC	$6.07B	-22.50%	-21.50%	-16.31%	-29.60%	0.04	26.10	100.00%	-10,097.00%	-10,096.95%
LTRN	LANTERN PHARMA INC	$31.43M	-198.30%	-129.10%	-461.79%	-732.60%	1.10	1.87	N/A	N/A	N/A
GERN	GERON CORP	$1.05B	-29.30%	-12.30%	-8.33%	-5.80%	1.37	6.92	93.50%	-33.10%	-18.27%
ARTV	ARTIVA BIOTHERAPEUTICS INC	$575.93M	-53.90%	-48.20%	-25.65%	-97.90%	0.06	24.16	N/A	N/A	N/A
PYPD	POLYPID LTD	$86.10M	-366.30%	-143.80%	-229.81%	-391.20%	1.03	1.97	N/A	N/A	N/A
SLS	SELLAS LIFE SCIENCES GROUP INC	$2.06B	-47.10%	-42.60%	-27.35%	4,971.60%	0.06	17.22	N/A	N/A	N/A
DNA	GINKGO BIOWORKS HOLDINGS INC	$505.73M	-60.20%	-26.90%	-31.77%	-24.20%	1.36	4.57	77.70%	-260.00%	-260.49%
PBLS	PARABILIS MEDICINES INC	N/A	N/A	N/A	N/A	N/A	-0.25	6.12	N/A	N/A	N/A
DARE	DARE BIOSCIENCE INC	$21.57M	N/A	-46.20%	-179.16%	113.60%	36.89	1.03	53.50%	-1,038.80%	-1,038.77%
LYEL	LYELL IMMUNOPHARMA INC	$364.64M	-91.60%	-70.50%	-91.59%	-93.70%	0.33	5.36	100.00%	-993,908.00%	-993,908.00%
MCRB	SERES THERAPEUTICS INC	$46.13M	-60.30%	-17.90%	-27.54%	-16.10%	1.94	2.11	100.00%	-1,192.90%	-1,192.94%
RCKT	ROCKET PHARMACEUTICALS INC	$384.21M	-5.80%	-4.90%	-1.72%	-3.90%	0.15	9.25	N/A	N/A	N/A
ABVX	ABIVAX SA	$10.01B	-98.60%	-69.80%	-44.05%	-1,055.50%	0.27	8.25	100.00%	-6,752.00%	-4,341.95%
NERV	MINERVA NEUROSCIENCES INC	$206.27M	N/A	-501.50%	-432.73%	-478.00%	-1.39	20.14	N/A	N/A	N/A
BBIO	BRIDGEBIO PHARMA INC	$16.39B	N/A	-65.80%	-116.69%	-32.30%	-1.60	1.52	95.10%	-124.40%	-111.59%
GALT	GALECTIN THERAPEUTICS INC	$206.13M	N/A	-165.90%	-220.99%	-21.00%	-1.11	2.15	N/A	N/A	N/A
AUTL	AUTOLUS THERAPEUTICS PLC	$620.14M	-128.60%	-46.30%	-54.09%	-32.90%	3.84	5.80	-11.20%	-312.00%	-270.67%
LTGO	LATIGO BIOTHERAPEUTICS INC	N/A	N/A	N/A	N/A	N/A	-0.06	3.23	N/A	N/A	N/A
INKT	MINK THERAPEUTICS INC	$55.95M	N/A	-118.60%	-403.62%	182.80%	-1.82	1.38	N/A	N/A	N/A
ANTX	AN2 THERAPEUTICS INC	$211.41M	-52.30%	-47.30%	-42.17%	-89.30%	0.07	15.73	N/A	N/A	N/A
CDXS	CODEXIS INC	$134.53M	-68.10%	-23.70%	-23.36%	-18.10%	1.99	5.36	88.90%	-41.00%	-34.26%
AVLN	AVALYN PHARMA INC	$1.57B	N/A	N/A	N/A	N/A	-0.11	11.03	N/A	N/A	N/A
INMB	INMUNE BIO INC	$57.73M	-82.90%	-62.20%	-87.88%	-1,798.40%	0.32	4.04	N/A	N/A	N/A
CBUS	CIBUS INC	$145.03M	-225.60%	-31.10%	-21.00%	-23.10%	8.14	2.37	100.00%	-2,366.30%	-1,520.35%
CAMP	CAMP4 THERAPEUTICS CORP	$216.53M	-194.70%	-95.60%	-97.15%	-12,049.00%	2.41	6.15	100.00%	-2,193.70%	-2,193.72%
AVXL	ANAVEX LIFE SCIENCES CORP	$325.28M	-38.80%	-35.00%	-31.54%	408.90%	0.05	20.87	N/A	N/A	N/A
COAG	HEMAB THERAPEUTICS HOLDINGS INC	$2.42B	N/A	N/A	N/A	N/A	-0.07	12.85	N/A	N/A	N/A
DOMH	DOMINARI HOLDINGS INC	$71.01M	-47.50%	-35.60%	N/A	-24.50%	1.70	N/A	100.00%	-31.40%	-17.98%
SNDX	SYNDAX PHARMACEUTICALS INC	$1.81B	-372.90%	-39.10%	-29.53%	-26.00%	45.60	6.77	95.80%	-87.50%	-70.71%
PTHS	PELTHOS THERAPEUTICS INC	$99.51M	-164.10%	-51.20%	-44.65%	-135.60%	3.14	2.79	79.60%	-186.20%	-194.02%
MGTX	MEIRAGTX HOLDINGS PLC	$1.21B	N/A	-55.00%	-158.37%	-83.30%	-5.21	0.55	95.40%	-151.10%	-136.08%
ANIX	ANIXA BIOSCIENCES INC	$109.55M	-65.50%	-62.90%	-75.08%	-77.10%	0.11	9.79	N/A	N/A	N/A
DSGN	DESIGN THERAPEUTICS INC	$914.94M	-34.00%	-32.10%	-34.72%	-36.00%	0.07	18.86	N/A	N/A	N/A
PRAX	PRAXIS PRECISION MEDICINES INC	$10.35B	-34.10%	-32.40%	-25.29%	-55.20%	0.04	15.73	N/A	N/A	N/A
VRAX	VIRAX BIOLABS GROUP LTD	$1.66M	-75.70%	-68.10%	-76.73%	-333.40%	0.13	9.97	61.90%	-40,439.10%	-47,188.42%
CYPH	CYPHERPUNK TECHNOLOGIES INC	$72.40M	-92.40%	-80.70%	-67.26%	-113.10%	0.04	27.28	N/A	N/A	N/A
LKFT	LAKEFRONT BIOTHERAPEUTICS NV	$1.89B	16.90%	13.90%	14.43%	15.00%	0.04	30.48	97.90%	49.70%	47.97%
KPTI	KARYOPHARM THERAPEUTICS INC	$47.59M	N/A	-176.90%	-1,045.36%	-88.40%	-1.50	1.08	96.00%	-129.00%	-97.64%
DNLI	DENALI THERAPEUTICS INC	$3.95B	-55.30%	-44.20%	-47.88%	-53.60%	0.39	8.37	97.40%	-14,191.20%	-14,188.37%
GRDX	GRIDAI TECHNOLOGIES CORP	$20.96M	-63.50%	-11.00%	-26.43%	-39.90%	1.10	0.16	-1,707.20%	-11,664.80%	-11,263.67%
CLRB	CELLECTAR BIOSCIENCES INC	$21.10M	-321.20%	-153.20%	-333.67%	1,004.80%	1.92	1.90	N/A	N/A	N/A
PEPG	PEPGEN INC	$200.85M	-51.00%	-43.50%	-54.28%	-69.90%	0.18	13.36	N/A	N/A	N/A
SLBT	SL SCIENCE HOLDING LTD	$1.50B	N/A	-5.30%	-162.64%	-5.40%	0.23	3.05	35.30%	-173.80%	-173.85%
DMRA	DAMORA THERAPEUTICS INC	$1.87B	-82.40%	-77.90%	-50.86%	1,686.80%	0.05	19.73	N/A	N/A	N/A
BNTC	BENITEC BIOPHARMA INC	$463.10M	-34.80%	-34.10%	-26.04%	-39,873.30%	0.02	56.82	N/A	N/A	N/A
CVM	CEL SCI CORP	$12.91M	-221.50%	-101.90%	-172.06%	-118.70%	1.58	0.60	N/A	N/A	N/A
OTLK	OUTLOOK THERAPEUTICS INC	$136.58M	N/A	-300.60%	366.05%	-2,177.20%	-1.76	0.54	-360.90%	-18,297.50%	-18,670.06%
LXEO	LEXEO THERAPEUTICS INC	$375.33M	-47.50%	-41.70%	-37.01%	-61.60%	0.08	14.16	N/A	N/A	N/A
RNTX	REIN THERAPEUTICS INC	$69.89M	-163.70%	-124.30%	-402.50%	976.80%	1.27	0.40	N/A	N/A	N/A
IBRX	IMMUNITYBIO INC	$8.05B	N/A	-172.90%	-159.13%	-62.70%	-1.60	5.72	99.30%	-598.60%	-529.60%
MANE	VERADERMICS INC	$4.55B	N/A	N/A	N/A	N/A	0.02	59.12	N/A	N/A	N/A
JANX	JANUX THERAPEUTICS INC	$1.01B	-10.80%	-10.10%	-10.83%	-10.80%	0.09	16.35	100.00%	-427.50%	-427.47%
IDYA	IDEAYA BIOSCIENCES INC	$3.55B	-16.50%	-15.10%	-14.26%	-19.30%	0.09	10.45	100.00%	-74.80%	-74.75%
PLRZ	POLYRIZON LTD	$16.39M	-25.40%	-24.70%	-29.77%	-73.60%	0.02	29.03	N/A	N/A	N/A
CLYM	CLIMB BIO INC	$795.49M	-31.80%	-30.80%	-23.97%	-37.40%	0.03	31.45	N/A	N/A	N/A
NMAD	NOMAD POWER SOLUTIONS INC	$44.08M	-126.20%	-96.80%	-74.84%	-174.20%	0.21	2.78	N/A	N/A	N/A
KURA	KURA ONCOLOGY INC	$881.53M	-142.00%	-43.30%	-53.18%	-58.80%	5.05	6.15	99.60%	-411.20%	-409.03%
GHRS	GH RESEARCH PLC	$2.00B	-20.90%	-20.10%	-17.24%	-220.00%	0.04	28.70	N/A	N/A	N/A
IRD	OPUS GENETICS INC	$322.80M	N/A	-174.90%	-125.83%	-12,171.30%	-8.16	12.19	100.00%	-1,091.80%	-1,089.81%
NKTR	NEKTAR THERAPEUTICS	$2.55B	-87.00%	-40.70%	-18.29%	-36.60%	0.33	10.21	100.00%	-284.20%	-232.01%
NRIX	NURIX THERAPEUTICS INC	$2.69B	-76.10%	-57.30%	-73.70%	-75.50%	0.33	6.34	100.00%	-928.40%	-929.18%
ROIV	ROIVANT SCIENCES LTD	$25.46B	-6.10%	-5.00%	-2.82%	-3.70%	0.09	16.72	81.20%	-3,535.00%	-1,879.06%
TECX	TECTONIC THERAPEUTIC INC	$623.04M	-35.30%	-33.60%	-37.68%	-22,463.10%	0.06	22.29	N/A	N/A	N/A
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$4.05B	-32.60%	-11.90%	-9.47%	-10.60%	3.43	4.80	75.60%	-20.70%	-16.99%
NUVB	NUVATION BIO INC	$2.24B	-49.70%	-23.50%	-18.72%	-19.00%	1.93	8.37	88.20%	-88.20%	-72.49%
CRBU	CARIBOU BIOSCIENCES INC	$167.62M	-100.10%	-72.00%	-103.44%	-78.30%	0.46	6.22	100.00%	-1,512.80%	-1,519.07%
KOD	KODIAK SCIENCES INC	$2.64B	-253.80%	-81.50%	-89.95%	-89.90%	1.73	3.54	N/A	N/A	N/A

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Aug 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 613 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: C, Momentum: B, Sentiment: A, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 45, which is 21 points higher than the biotech industry average of 24.

PBYI passed 14 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock return 80.82% over the past year, overperforming other biotech stocks by 88 percentage points.

Puma Biotechnology has an average 1 year price target of $6.00, a downside of -31.58% from Puma Biotechnology's current stock price of $8.77.

Puma Biotechnology stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Immucell (NASDAQ:ICCC)

Immucell (NASDAQ:ICCC) is the #2 top biotech stock out of 613 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Immucell (NASDAQ:ICCC) is: Value: C, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Immucell (NASDAQ:ICCC) has a Due Diligence Score of 19, which is -5 points lower than the biotech industry average of 24. Although this number is below the industry average, our proven quant model rates ICCC as a "A".

ICCC passed 6 out of 33 due diligence checks and has weak fundamentals. Immucell has seen its stock return 64.41% over the past year, overperforming other biotech stocks by 71 percentage points.

3. Corcept Therapeutics (NASDAQ:CORT)

Corcept Therapeutics (NASDAQ:CORT) is the #3 top biotech stock out of 613 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Corcept Therapeutics (NASDAQ:CORT) is: Value: B, Growth: A, Momentum: B, Sentiment: B, Safety: C, Financials: B, and AI: C.

Corcept Therapeutics (NASDAQ:CORT) has a Due Diligence Score of 50, which is 26 points higher than the biotech industry average of 24.

CORT passed 17 out of 33 due diligence checks and has strong fundamentals. Corcept Therapeutics has seen its stock return 55.43% over the past year, overperforming other biotech stocks by 62 percentage points.

Corcept Therapeutics has an average 1 year price target of $122.60, an upside of 9.6% from Corcept Therapeutics's current stock price of $111.86.

Corcept Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Corcept Therapeutics, 60% have issued a Strong Buy rating, 20% have issued a Buy, 0% have issued a hold, while 20% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 7 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 31.05%, which is 26 percentage points higher than the biotech industry average of 5.37%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

Oramed Pharmaceuticals (NASDAQ:ORMP) has an annual dividend yield of 5.88%, which is 1 percentage points higher than the biotech industry average of 5.37%.

Oramed Pharmaceuticals's dividend payout ratio of 5.9% indicates that its high dividend yield is sustainable for the long-term.

3. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.7%, which is -3 percentage points lower than the biotech industry average of 5.37%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% nine times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 46.1% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.12% in the last day, and up 3.4% over the last week. Pds Biotechnology was the among the top losers in the biotechnology industry, dropping -64.84% yesterday.

PDS Biotechnology shares are trading lower after the company issued CEO letter outlining plans to advance PDS0301 and pursue partnerships for PDS0101 after ceasing internal investment in its Phase 3 study.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Exelixis (NASDAQ:EXEL)

Exelixis (NASDAQ:EXEL) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Exelixis has a valuation score of 14, which is 1 points higher than the biotech industry average of 13. It passed 1 out of 7 valuation due diligence checks.

Exelixis's stock has gained 37.21% in the past year. It has overperformed other stocks in the biotech industry by 44 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 43, which is 30 points higher than the biotech industry average of 13. It passed 3 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 13.56% in the past year. It has overperformed other stocks in the biotech industry by 20 percentage points.

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Jazz Pharmaceuticals has a valuation score of 57, which is 44 points higher than the biotech industry average of 13. It passed 4 out of 7 valuation due diligence checks.

Jazz Pharmaceuticals's stock has gained 123.91% in the past year. It has overperformed other stocks in the biotech industry by 131 percentage points.

Are biotech stocks a good buy now?

68.09% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 48.53% over the next year.

3.46% of biotech stocks have a Zen Rating of A (Strong Buy), 4.11% of biotech stocks are rated B (Buy), 41.77% are rated C (Hold), 38.96% are rated D (Sell), and 11.69% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is 16.08x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Immucell (NASDAQ:ICCC)

3. Corcept Therapeutics (NASDAQ:CORT)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Exelixis (NASDAQ:EXEL)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2026)Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Immucell (NASDAQ:ICCC)

3. Corcept Therapeutics (NASDAQ:CORT)

1. Dominari Holdings (NASDAQ:DOMH)

2. Oramed Pharmaceuticals (NASDAQ:ORMP)

3. Novo Nordisk (Ozempic) (NYSE:NVO)

1. Exelixis (NASDAQ:EXEL)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2026)
Top biotech stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best biotech stocks to buy now. Learn More.